Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Propionic Acid in Multiple Sclerosis: Safety, Tolerability and Clinical Outcomes From the Pro-MADAI Study

NCT07595081 is registered in ClinicalTrials.gov with Salzburger Landeskliniken as lead sponsor.

NCT NCT07595081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07595081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Propionic Acid in Multiple Sclerosis: Safety, Tolerability and Clinical Outcomes From the Pro-MADAI Study
Lead sponsor
Salzburger Landeskliniken
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2024
Completion date
December 12, 2025
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis